JoVE Logo
Faculty Resource Center

Sign In

Summary

Abstract

Introduction

Protocol

Representative Results

Discussion

Acknowledgements

Materials

References

Genetics

An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations

Published: April 21st, 2023

DOI:

10.3791/65316

1Josep Carreras Leukaemia Research Institute, 2Barcelona Supercomputing Center, 3Catalan Institution for Research and Advanced Studies (ICREA), 4Institute for Health Science Research Germans Trias i Pujol
* These authors contributed equally

Gene expression is regulated by interactions of gene promoters with distal regulatory elements. Here, we descirbe how low input Capture Hi-C (liCHi-C) allows the identification of these interactions in rare cell types, which were previously unmeasurable.

Spatiotemporal gene transcription is tightly regulated by distal regulatory elements, such as enhancers and silencers, which rely on physical proximity with their target gene promoters to control transcription. Although these regulatory elements are easy to identify, their target genes are difficult to predict, since most of them are cell-type specific and may be separated by hundreds of kilobases in the linear genome sequence, skipping over other non-target genes. For several years, Promoter Capture Hi-C (PCHi-C) has been the gold standard for the association of distal regulatory elements to their target genes. However, PCHi-C relies on the availability of millions of cells, prohibiting the study of rare cell populations such as those commonly obtained from primary tissues. To overcome this limitation, low input Capture Hi-C (liCHi-C), a cost-effective and customizable method to identify the repertoire of distal regulatory elements controlling each gene of the genome, has been developed. liCHi-C relies on a similar experimental and computational framework as PCHi-C, but by employing minimal tube changes, modifying the reagent concentration and volumes, and swapping or eliminating steps, it accounts for minimal material loss during library construction. Collectively, liCHi-C enables the study of gene regulation and spatiotemporal genome organization in the context of developmental biology and cellular function.

Temporal gene expression drives cell differentiation and, ultimately, organism development, and its alteration is closely related to a wide plethora of diseases1,2,3,4,5. Gene transcription is finely regulated by the action of regulatory elements, which can be classified as proximal (i.e., gene promoters) and distal (e.g., enhancers or silencers), the latter of which are frequently located afar from their target genes and physically interact with them through chromatin looping to modulate gene expression

Log in or to access full content. Learn more about your institution’s access to JoVE content here

To ensure minimal material loss, (1) work with DNA low-binding tubes and tips (see Table of Materials), (2) place reagents on the tube wall instead of introducing the tip inside the sample and, (3) if possible, mix the sample by inversion instead of pipetting the sample up and down, and spin down afterward to recover the sample.

1. Cell fixation

  1. Cells growing in suspension
    1. Harvest 50,000 to one million cells and place them in a DNA low-.......

Log in or to access full content. Learn more about your institution’s access to JoVE content here

liCHi-C offers the possibility of generating high-quality and resolution genome-wide promoter interactome libraries with as little as 50,000 cells53. This is accomplished by – besides the drastic reduction of reaction volumes and the use of DNA low-binding plasticware throughout the protocol – removing unnecessary steps from the original protocol, in which significant material losses occur. These include the phenol purification after decrosslinking, the biotin removal, and subsequ.......

Log in or to access full content. Learn more about your institution’s access to JoVE content here

liCHi-C offers the capability of generating high-resolution promoter interactome libraries using a similar experimental framework from PCHi-C's but with a vastly reduced cell number. This is greatly achieved by eliminating unnecessary steps, such as phenol purification and biotin removal. In the classical in-nucleus ligation Hi-C protocol57 and its subsequent derivative technique PCHi-C, biotin is removed from non-ligated restriction fragments to avoid pulling down DNA fragments that are after.......

Log in or to access full content. Learn more about your institution’s access to JoVE content here

We thank the rest of the members from the Javierre lab for their feedback on the manuscript. We thank CERCA Program, Generalitat de Catalunya, and the Josep Carreras Foundation for institutional support. This work was financed by FEDER/Spanish Ministry of Science and Innovation (RTI2018-094788-A-I00), the European Hematology Association (4823998), and the Spanish Association against Cancer (AECC) LABAE21981JAVI. BMJ is funded by La Caixa Banking Foundation Junior Leader project (LCF/BQ/PI19/11690001), LR is funded by an AGAUR FI fellowship (2019FI-B00017), and LT-D is funded by an FPI Fellowship (PRE2019-088005). We thank the biochemistry and molecular biology PhD pro....

Log in or to access full content. Learn more about your institution’s access to JoVE content here

NameCompanyCatalog NumberComments
0.4 mM Biotin-14-dATPInvitrogen19524-016
0.5 M EDTA pH 8.0InvitrogenAM9260G
1 M Tris pH 8.0InvitrogenAM9855G
10x NEBuffer 2New England BiolabsB7002SReferenced as restriction buffer 2 in the manuscript
10x PBSFisher ScientificBP3994
10x T4 DNA ligase reaction bufferNew England BiolabsB0202S
16% formaldehyde solution (w/v), methanol-freeThermo Scientific28908
20 mg/mL Bovine Serum AlbuminNew England BiolabsB9000S
5 M NaClInvitrogenAM9760G
5PRIME Phase Lock Gel Light tubesQiuantabio2302820For phenol-chloroform purification in section 4 (DNA purification). Phase Lock Gel tubes are a commercial type of tubes specially designed to maximize DNA recovery after phenol-chloroform purifications while avoiding carryover of contaminants in the organic phase by containing a resin of intermediate density which settles between the organic and aqueous phase and isolates them. PLG tubes should be spun at 12,000 x g for 30 s before use to ensure that the resin is well-placed at the bottom of the tube
Adapters and PCR primers for library amplificationIntegrated DNA Technologies-Bought as individual primers with PAGE purification for NGS
Cell scrappersNunc179693Or any other brand
Centrifuge (fixed-angle rotor for 1.5 mL tubes)Any brand
CHiCAGO R package1.14.0
CleanNGS beadsCleanNACNGS-0050
dATP, dCTP, dGTP, dTTPPromegaU120A, U121A, U122A, U123AOr any other brand
DNA LoBind tube, 1.5 mLEppendorf30108051
DNA LoBind tube, 2 mLEppendorf30108078
DNA polymerase I large (Klenow) fragment 5000 units/mLNew England BiolabsM0210L
Dynabeads MyOne Streptavidin C1 beadsInvitrogen65002For biotin pull-down of the pre-captured library in section 8 (biotin pull-down)
Dynabeads MyOne Streptavidin T1 beadsInvitrogen65602For biotin pull-down of the post-captured library in section 11 (biotin pull-down and PCR amplification)
DynaMag-2Invitrogen12321DOr any other magnet suitable for 1.5 ml tubeL
Ethanol absoluteVWR20821.321
FBS, qualifiedGibco10270-106Or any other brand
GlycineFisher BioReagentsBP381-1
GlycoBlue CoprecipitantInvitrogenAM9515Used for DNA coprecipitation in section 4 (DNA purification)
HiCUP0.8.2
HindIII, 100 U/µLNew England BiolabsR0104T
IGEPAL CA-630Sigma-AldrichI8896-50ML
Klenow EXO- 5000 units/mLNew England BiolabsM0212L
Low-retention filter tips (10 µL, 20 µL, 200 µL and 1000 µL)ZeroTipPMT233010, PMT252020, PMT231200, PMT252000
M220 Focused-ultrasonicatorCovaris500295
Micro TUBE AFA Fiber Pre-slit snap cap 6 x 16 mm vialsCovaris520045For sonication in section 6 (sonication)
NheI-HF, 100 U/µLNew England BiolabsR3131M
Nuclease-free molecular biology grade waterSigma-AldrichW4502
PCR primers for quality controlsIntegrated DNA Technologies-
PCR strips and capsAgilent Technologies410022, 401425
Phenol: Chloroform: Isoamyl Alcohol 25:24:1, Saturated with 10 mM Tris, pH 8.0, 1 mM EDTASigma-AldrichP3803
Phusion High-Fidelity PCR Master Mix with HF BufferNew England BiolabsM0531LFor amplification of the library in sections 9 (dATP-tailing, adapter ligation and PCR amplification)
and 11 (biotin pull-down and PCR amplification)
Protease inhibitor cocktail (EDTA-free)Roche11873580001
Proteinase K, recombinant, PCR gradeRoche3115836001
Qubit 1x dsDNA High Sensitivity kitInvitrogenQ33230For DNA quantification after precipitation in section 4 (DNA purification)
Qubit assay tubesInvitrogenQ32856
rCutsmart bufferNew England BiolabsB6004S
RPMI Medium 1640 1x + GlutaMAXGibco61870-010Or any other brand
SDS - Solution 10% for molecular biologyPanReac AppliChemA0676
Sodium acetate pH 5.2Sigma-AldrichS7899-100ML
SureSelect custom 3-5.9 Mb libraryAgilent Technologies5190-4831Custom designed mouse or human capture system, used for the capture
SureSelect Target Enrichment Box 1Agilent Technologies5190-8645Used for the capture
SureSelect Target Enrichment Kit ILM PE Full AdapterAgilent Technologies931107Used for the capture
T4 DNA ligase 1 U/µLInvitrogen15224025For ligation in section 3 (ligation and decrosslink)
T4 DNA ligase 2000000/mLNew England BiolabsM0202TFor ligation in section 9 (dATP-tailing, adapter ligation and PCR amplification)
T4 DNA polymerase 3000 units/mLNew England BiolabsM0203L
T4 PNK 10000 units/mLNew England BiolabsM0201L
Tapestation 4200 instrumentAgilent TechnologiesFor automated electrophoresis in section 9 (dATP-tailing, adapter ligation, and PCR amplification) and
section 11
(Biotin pull-down and PCR amplification). Any other automated electrophoresis system is valid
Tapestation reagentsAgilent Technologies5067-5582, 5067-5583, 5067-5584, 5067-5585,For automated electrophoresis in section 9 (dATP-tailing, adapter ligation, and PCR amplification) and
section 11
(Biotin pull-down and PCR amplification). Any other automated electrophoresis system is valid
Triton X-100 for molecular biologyPanReac AppliChemA4975
Tween 20Sigma-AldrichP9416-50ML

  1. Hatton, C. S., et al. α-thalassemia caused by a large (62 kb) deletion upstream of the human α globin gene cluster. Blood. 76 (1), 221-227 (1990).
  2. Toikkanen, S., Helin, H., Isola, J., Joensuu, H. Prognostic significance of HER-2 oncoprotein expression in breast cancer: A 30-year follow-up. Journal of Clinical Oncology. 10 (7), 1044-1048 (1992).
  3. Church, C., et al. Overexpression of Fto leads to increased food intake and results in obesity. Nature Genetics. 42 (12), 1086-1092 (2010).
  4. Bhatia, S., et al. Disruption of autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer causes aniridia. American Journal of Human Genetics. 93 (6), 1126-1134 (2013).
  5. Herranz, D., et al. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nature Medicine. 20 (10), 1130-1137 (2014).
  6. Carter, D., Chakalova, L., Osborne, C. S., Dai, Y. F., Fraser, P. Long-range chromatin regulatory interactions in vivo. Nature Genetics. 32 (4), 623-626 (2002).
  7. Rao, S. S. P., et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell. 159 (7), 1665-1680 (2014).
  8. Schoenfelder, S., Fraser, P. Long-range enhancer-promoter contacts in gene expression control. Nature Reviews Genetics. 20 (8), 437-455 (2019).
  9. Heintzman, N. D., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nature Genetics. 39 (3), 311-318 (2007).
  10. Zentner, G. E., Tesar, P. J., Scacheri, P. C. Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions. Genome Research. 21 (8), 1273-1283 (2011).
  11. Creyghton, M. P., et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proceedings of the National Academy of Sciences. 107 (50), 21931-21936 (2010).
  12. McPherson, C. E., Shim, E. Y., Friedman, D. S., Zaret, K. S. An active tissue-specific enhancer and bound transcription factors existing in a precisely positioned nucleosomal array. Cell. 75 (2), 387-398 (1993).
  13. He, A., Kong, S. W., Ma, Q., Pu, W. T. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proceedings of the National Academy of Sciences. 108 (14), 5632-5637 (2011).
  14. Dogan, N., et al. Occupancy by key transcription factors is a more accurate predictor of enhancer activity than histone modifications or chromatin accessibility. Epigenetics and Chromatin. 8, 16 (2015).
  15. Whyte, W. A., et al. transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 153 (2), 307-319 (2013).
  16. Hnisz, D., et al. Super-enhancers in the control of cell identity and disease. Cell. 155 (4), 934-947 (2013).
  17. He, H. H., et al. Nucleosome dynamics define transcriptional enhancers. Nature Genetics. 42 (4), 343-347 (2010).
  18. Song, L., et al. Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Research. 21 (10), 1757-1767 (2011).
  19. De Santa, F., et al. A large fraction of extragenic RNA Pol II transcription sites overlap enhancers. PLoS Biology. 8 (5), e1000384 (2010).
  20. Kim, T. K., et al. Widespread transcription at neuronal activity-regulated enhancers. Nature. 465 (7295), 182-187 (2010).
  21. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 489 (7414), 57-74 (2012).
  22. Wu, H., et al. Tissue-specific RNA expression marks distant-acting developmental enhancers. PLoS Genetics. 10 (9), e1004610 (2014).
  23. Banerji, J., Rusconi, S., Schaffner, W. Expression of a β-globin gene is enhanced by remote SV40 DNA sequences. Cell. 27 (2), 299-308 (1981).
  24. Amano, T., et al. Chromosomal dynamics at the Shh locus: limb bud-specific differential regulation of competence and active transcription. Developmental Cell. 16 (1), 47-57 (2009).
  25. Shi, J., et al. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes and Development. 27 (24), 2648-2662 (2013).
  26. Lettice, L. A., et al. A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Human Molecular Genetics. 12 (14), 1725-1735 (2003).
  27. Tuvikene, J., et al. Intronic enhancer region governs transcript-specific Bdnf expression in rodent neurons. eLife. 10, e65161 (2021).
  28. Tasic, B., et al. Promoter choice determines splice site selection in protocadherin α and γ pre-mRNA splicing. Molecular Cell. 10 (1), 21-33 (2002).
  29. Perry, M. W., Boettiger, A. N., Levine, M. Multiple enhancers ensure precision of gap gene-expression patterns in the Drosophila embryo. Proceedings of the National Academy of Sciences. 108 (33), 13570-13575 (2011).
  30. Lieberman-Aiden, E., et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science. 326 (5950), 289-293 (2009).
  31. Fullwood, M. J., et al. An oestrogen-receptor-α-bound human chromatin interactome. Nature. 462 (7269), 58-64 (2009).
  32. Mumbach, M. R., et al. HiChIP: Efficient and sensitive analysis of protein-directed genome architecture. Nature Methods. 13 (11), 919-922 (2016).
  33. Sati, S., et al. HiCuT: An efficient and low input method to identify protein-directed chromatin interactions. PLoS Genetics. 18 (3), e1010121 (2022).
  34. Schoenfelder, S., et al. The pluripotent regulatory circuitry connecting promoters to their long-range interacting elements. Genome Research. 25 (4), 582-597 (2015).
  35. Schoenfelder, S., Javierre, B. M., Furlan-Magaril, M., Wingett, S. W., Fraser, P. Promoter capture Hi-C: High-resolution, genome-wide profiling of promoter interactions. Journal of Visualized Experiments. (136), e57320 (2018).
  36. Rubin, A. J., et al. Lineage-specific dynamic and pre-established enhancer-promoter contacts cooperate in terminal differentiation. Nature Genetics. 49 (10), 1522-1528 (2017).
  37. Siersbæk, R., et al. Dynamic rewiring of promoter-anchored chromatin loops during adipocyte differentiation. Molecular Cell. 66 (3), 420-435 (2017).
  38. Schoenfelder, S., et al. Polycomb repressive complex PRC1 spatially constrains the mouse embryonic stem cell genome. Nature Genetics. 47 (10), 1179-1186 (2015).
  39. Zhang, N., et al. Muscle progenitor specification and myogenic differentiation are associated with changes in chromatin topology. Nature Communications. 11 (1), 6222 (2020).
  40. Javierre, B. M., et al. Lineage-specific genome architecture links enhancers and non-coding disease variants to target gene promoters. Cell. 167 (5), 1369-1384 (2016).
  41. Jäger, R., et al. Capture Hi-C identifies the chromatin interactome of colorectal cancer risk loci. Nature Communications. 6, 6178 (2015).
  42. Martin, P., et al. Identifying causal genes at the multiple sclerosis associated region 6q23 using capture Hi-C. PLoS One. 11 (11), e0166923 (2016).
  43. Burren, O. S., et al. Chromosome contacts in activated T cells identify autoimmune disease candidate genes. Genome Biology. 18 (1), 165 (2017).
  44. Choy, M. K., et al. Promoter interactome of human embryonic stem cell-derived cardiomyocytes connects GWAS regions to cardiac gene networks. Nature Communications. 9 (1), 2526 (2018).
  45. Miguel-Escalada, I., et al. Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes. Nature Genetics. 51 (7), 1137-1148 (2019).
  46. Law, P. J., et al. Association analyses identify 31 new risk loci for colorectal cancer susceptibility. Nature Communications. 10 (1), 2154 (2019).
  47. Speedy, H. E., et al. Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics. Nature Communications. 10 (1), 3615 (2019).
  48. Li, T., et al. Epigenomics and transcriptomics of systemic sclerosis CD4+ T cells reveal long-range dysregulation of key inflammatory pathways mediated by disease-associated susceptibility loci. Genome Medicine. 12 (1), 81 (2020).
  49. Orlando, G., et al. Promoter capture Hi-C-based identification of recurrent noncoding mutations in colorectal cancer. Nature Genetics. 50 (10), 1375-1380 (2018).
  50. Cornish, A. J., et al. Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C. Blood Advances. 3 (1), 21-32 (2019).
  51. Madsen, J. G. S., et al. Highly interconnected enhancer communities control lineage-determining genes in human mesenchymal stem cells. Nature Genetics. 52 (11), 1227-1238 (2020).
  52. Dryden, N. H., et al. Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C. Genome Research. 24 (11), 1854-1868 (2014).
  53. Tomás-Daza, L., et al. Low input capture Hi-C (liCHi-C) identifies promoter-enhancer interactions at high-resolution. Nature Communications. 14 (1), 268 (2023).
  54. Lee, P. Y., Costumbrado, J., Hsu, C. Y., Kim, Y. H. Agarose gel electrophoresis for the separation of DNA fragments. Journal of Visualized Experiments. 62 (62), e3923 (2012).
  55. Bronner, I. F., Quail, M. A. Best practices for Illumina library preparation. Current Protocols in Human Genetics. 102 (1), 86 (2019).
  56. Wingett, S., et al. HiCUP: pipeline for mapping and processing Hi-C data. F1000Research. 4, 1310 (2015).
  57. Nagano, T., et al. Comparison of Hi-C results using in-solution versus in-nucleus ligation. Genome Biology. 16 (1), 175 (2015).
  58. Cairns, J., et al. CHiCAGO: Robust detection of DNA looping interactions in Capture Hi-C data. Genome Biology. 17 (1), 127 (2016).
  59. Freire-Pritchett, P., et al. Detecting chromosomal interactions in Capture Hi-C data with CHiCAGO and companion tools. Nature Protocols. 16 (9), 4144-4176 (2021).
  60. Kihm, A. J., et al. An abundant erythroid protein that stabilizes free α-haemoglobin. Nature. 417 (6890), 758-763 (2002).
  61. Feng, L., et al. Molecular mechanism of AHSP-mediated stabilization of α-hemoglobin. Cell. 119 (5), 629-640 (2004).
  62. Favero, M. E., Costa, F. F. Alpha-hemoglobin-stabilizing protein: An erythroid molecular chaperone. Biochemistry Research International. 2011, 373859 (2011).
  63. Li, D., et al. WashU Epigenome Browser update 2022. Nucleic Acids Research. 50 (W1), W774-W781 (2022).
  64. Mifsud, B., et al. Mapping long-range promoter contacts in human cells with high-resolution capture Hi-C. Nature Genetics. 47 (6), 598-606 (2015).
  65. Nagano, T., et al. Single-cell Hi-C reveals cell-to-cell variability in chromosome structure. Nature. 502 (7469), 59-64 (2013).
  66. Tan, L., Xing, D., Chang, C. H., Li, H., Xie, X. S. 3D genome structures of single diploid human cells. Science. 361 (6405), 924 (2018).
  67. Ramani, V., et al. Massively multiplex single-cell Hi-C. Nature Methods. 14 (3), 263-266 (2017).
  68. Díaz, N., et al. Chromatin conformation analysis of primary patient tissue using a low input Hi-C method. Nature Communications. 9 (1), 4938 (2018).
  69. Lu, L., Jin, F. Easy Hi-C: A low-input method for capturing genome organization. Methods in Molecular Biology. 2599, 113-125 (2023).

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved